What is the main business of Synoptis Pharma?

The main business activity of Synoptis Pharma focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 29, 2004.

Where is the headquarters located?

The headquarters is located at: Krakowiaków 65, 02-255 Warszawa.

What is the share capital?

The share capital of the company is PLN 18,000,000 (approx. $4.9 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

The company reported a revenue of $79,311,001 in 2025, which is an increase of 25.0% compared to 2024.

Is the company profitable?

Yes, in 2025 the company was profitable, achieving a net profit of $13,580,708, meaning the company increased its profit by 145.9%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $40,574,811 in 2025, representing 66% of all operating expenses.

Synoptis Pharmasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2004-12-29

Share capital

18 000 000,00 PLN

Registered address

Krakowiaków 65, 02-255 Warszawa, Poland

Electronic delivery address

AE:PL-36726-19314-HDESR-28

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 79.31mMedianUSD 816.16kAverageUSD 29.28m

Net profit

This companyUSD 13.58mMedianUSD 8.96kAverageUSD 2.64m

Operating costs

This companyUSD 61.31mMedianUSD 701.47kAverageUSD 19.26m

Assets

This companyUSD 33.74mMedianUSD 800.13kAverageUSD 29.34m

Industry

Bank accounts

Registered as a VAT taxpayer on 2005-01-17. Active

Bank Millennium
37 1160 2202 0000 0001 1318 2648
Bank Millennium
50 1160 2202 0000 0001 6508 4398
Bank Millennium
66 1160 2202 0000 0002 3652 1506

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
KNF	Consumer credit intermediary	Active
BDO	BDO register entry	Active

Authorized Representatives

Aleksandra Puskarz Kusa — Attorney-in-fact (joint)

Andrzej Zieliński — Attorney-in-fact (joint)

Katarzyna Iwaszkiewicz Balsam — President of the Management Board

Dorota Katarzyna Kruszewska — Attorney-in-fact (joint)

Manner of representation

The making of declarations on behalf of the company requires the joint action of two members of the management board, or of one member of the management board jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Neuca S.A.	360,000	$4,862,236.63	100%

Beneficial owners

6 beneficial owners recorded in CRBR.

Person	Rights
Aleks Herba (10)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów spółki
Filip Herba (32)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów spółki
Katarzyna Herba (33)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów spółki
Kazimierz Michał Herba (61)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów spółki
Mateusz Herba (17)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów spółki
Marta Herba Holszańska (50)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów spółki

Subsidiaries

	Name	Share value	Stake
	Synoptis Industrialsp. z o.o.	4,402,957.86 USD	99.9985%

Competitors

Name	Revenue	Website
Anpharm Przedsiębiorstwo FarmaceutyczneS.A.	$111,469,394.21	anpharm.pl
Tarchomińskie Zakłady Farmaceutyczne PolfaS.A.	$102,988,448.02	polfa-tarchomin.com.pl
VercoS.A.	$43,577,172.02	verco.com.pl
MedicofarmaS.A.	$8,530,473.72	medicofarma.pl
VitamaS.A.	$4,287,087.38	vitama.pl
Munar PharmaS.A.	$85,649.72	munar.pl
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com
Stg25Branch (foreign co.)	—	glagolica.eu

Change history

Date	Event
2015-07-02	PKD change (Removed: 17.22.Z, 17.23.Z, 20.42.Z, 20.53.Z, 45.11.Z, 45.19.Z, 46.39.Z, 46.65.Z, 46.66.Z, 46.69.Z, 46.71.Z, 46.90.Z, 47.29.Z, 47.74.Z, 47.78.Z, 49.39.Z, 49.41.Z, 52.10.B, 53.20.Z, 58.13.Z, 58.14.Z, 58.19.Z, 58.29.Z, 62.01.Z, 62.02.Z, 63.11.Z, 63.12.Z, 64.99.Z, 66.19.Z, 66.22.Z, 68.10.Z, 68.20.Z, 68.32.Z, 69.20.Z, 70.21.Z, 70.22.Z, 73.11.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D, 73.20.Z, 74.90.Z, 77.12.Z, 77.33.Z, 78.10.Z, 78.20.Z, 78.30.Z, 79.11.A, 79.11.B, 79.12.Z, 82.20.Z, 82.30.Z, 82.92.Z, 85.59.B, 86.10.Z, 86.90.D; Added: 46.74.Z)
2012-10-23	Address change (Taśmowa 7, 02-677, Warszawa → Krakowiaków 65, 02-255, Warszawa)
2010-11-30	Address change (Aleje Jerozolimskie 151, 02-326, Warszawa → Taśmowa 7, 02-677, Warszawa)
2010-11-30	Share capital change (14,000,000.00 PLN → 18,000,000.00 PLN)
2010-02-16	Share capital change (55,000.00 PLN → 14,000,000.00 PLN)

FAQ

Last updated: 2026-06-11